Literature DB >> 6219882

Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function.

R Palacios, K Guy, V Van Heyningen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6219882     DOI： 10.1002/eji.1830130114

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  4 in total

1.  OKT4+ and OKT8+ T lymphocytes produce soluble factors that can modulate growth and differentiation of human B cells.

Authors:  T Sakane; Y Ueda; N Suzuki; Y Niwa; T Hoshino; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production.

Authors:  A Eisenthal; J Monselise; R Zinger; A Adler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes.

Authors:  R Palacios; O Martinez-Maza; K Guy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 4.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.